Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12564650 | Carbonic anhydrase IX-targeting radioactive diagnostic and therapeutic medicament and method for preparing same | 🖼🧊📄§ | 2026-03-03 | 2044-08-14 | 0 | 31 |
| 12564599 | Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight | 🖼🧊📄§ | 2026-03-03 | 2040-02-21 | 0 | 31 |
| 12566180 | Methods of diagnosing or treating Lyme disease | 🖼🧊📄§ | 2026-03-03 | 2044-04-19 | 0 | 31 |
| 12565510 | Phospholipid | 🖼🧊📄§ | 2026-03-03 | 2042-06-02 | 0 | 31 |
| 12565660 | Immunomodulating transgenic plants and related methods | 🖼🧊📄§ | 2026-03-03 | 2044-01-24 | 0 | 31 |
| 12564546 | Self-tanning compositions containing an aromatic sulfonate and methods thereof | 🖼🧊📄§ | 2026-03-03 | 2041-04-28 | 0 | 31 |
| 12565526 | Formulations of anti-RSV antibodies and methods of use thereof | 🖼🧊📄§ | 2026-03-03 | 2039-10-14 | 0 | 31 |
| 12560591 | Methods of treatment with CD8 T cell-mediated immune therapy | 🖼🧊📄§ | 2026-02-24 | 2040-09-11 | 0 | 31 |
| 12558416 | Endothelium-specific nucleic acid regulatory elements and methods and use thereof | 🖼🧊📄§ | 2026-02-24 | 2042-07-26 | 0 | 31 |
| 12559737 | Cas9 variants and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2040-11-24 | 0 | 31 |
| 12558336 | Metabolic rescue of retinal degeneration | 🖼🧊📄§ | 2026-02-24 | 2040-09-24 | 0 | 31 |
| 12558329 | Methods and compositions for treating 4-hydroxyphenylpyruvate dioxygenase-like (HPDL)-related diseases or disorders | 🖼🧊📄§ | 2026-02-24 | 2042-01-19 | 0 | 31 |
| 12559473 | Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs | 🖼🧊📄§ | 2026-02-24 | 2044-04-30 | 0 | 31 |
| 12559757 | Regulation of gene expression through aptamer-modulated polyadenylation | 🖼🧊📄§ | 2026-02-24 | 2043-05-23 | 0 | 31 |
| 12558308 | Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents | 🖼🧊📄§ | 2026-02-24 | 2043-01-25 | 0 | 31 |
| 12559749 | Methods of rescuing stop codons via genetic reassignment with ACE-tRNA | 🖼🧊📄§ | 2026-02-24 | 2043-04-21 | 0 | 31 |
| 12560611 | Ratio between PLGF and sFLt1 is predictive for neural invasion in patients suffering from pancreatic cancer | 🖼🧊📄§ | 2026-02-24 | 2041-07-08 | 0 | 31 |
| 12558397 | Composition for prevention, amelioration, or treatment of urination-related diseases comprising cephalotocin | 🖼🧊📄§ | 2026-02-24 | 2042-10-07 | 0 | 31 |
| 12558354 | Tumor necrosis factor alpha (TNF-alpha) small molecule inhibitor | 🖼🧊📄§ | 2026-02-24 | 2040-11-05 | 0 | 31 |
| 12558384 | Compositions and methods to increase production of isothiocyanates | 🖼🧊📄§ | 2026-02-24 | 2043-09-14 | 0 | 31 |
| 12558328 | Solid-forming topical formulations for pain control | 🖼🧊📄§ | 2026-02-24 | 2042-02-11 | 0 | 31 |
| 12558426 | Method of delivering proteins into cells | 🖼🧊📄§ | 2026-02-24 | 2043-08-09 | 0 | 31 |
| 12558383 | American cockroach extract, preparation thereof, preparation methods therefor and applications thereof | 🖼🧊📄§ | 2026-02-24 | 2040-10-10 | 0 | 31 |
| 12558370 | Intact pea protein-based nutrient composition | 🖼🧊📄§ | 2026-02-24 | 2038-06-12 | 0 | 31 |
| 12558373 | Method for converting atrial fibrillation to sinus rhythm with low-risk, low-cost protocol, and preventing recurrence of atrial fibrillation | 🖼🧊📄§ | 2026-02-24 | 2044-10-04 | 0 | 31 |
| 12558411 | Antigen composition for preventing or treating viral infectious diseases | 🖼🧊📄§ | 2026-02-24 | 2041-01-15 | 0 | 31 |
| 12558338 | Pharmaceutical composition | 🖼🧊📄§ | 2026-02-24 | 2040-10-14 | 0 | 31 |
| 12560570 | Diffusion resistance layer for analyte sensors | 🖼🧊📄§ | 2026-02-24 | 2042-12-27 | 0 | 31 |
| 12559499 | Uses of compounds having anti-HSV-1 activity | 🖼🧊📄§ | 2026-02-24 | 2040-01-29 | 0 | 31 |
| 12559725 | Formulation comprising extracellular vesicles, method for producing the same, and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2039-12-04 | 0 | 31 |
| 12558392 | Herbal oral compositions having the properties for supporting and enhancing musculoskeletal health and method of manufacturing the same | 🖼🧊📄§ | 2026-02-24 | 2045-07-23 | 0 | 31 |
| 12559534 | Modified IL-2 proteins, peg conjugates, and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2040-06-18 | 0 | 31 |
| 12558400 | Method of treatment of soft tissue sarcoma with a peptide comrpising a PCNA interacting motif | 🖼🧊📄§ | 2026-02-24 | 2041-04-27 | 0 | 31 |
| 12559723 | Platform for generating safe cell therapeutics | 🖼🧊📄§ | 2026-02-24 | 2042-12-15 | 0 | 31 |
| 12558340 | ANAVEX2-73 for the treatment of genetic neurodevelopmental disorders | 🖼🧊📄§ | 2026-02-24 | 2042-01-21 | 0 | 31 |
| 12558344 | Composition for preventing or treating brain-nervous system diseases comprising rita or derivatives thereof | 🖼🧊📄§ | 2026-02-24 | 2042-06-03 | 0 | 31 |
| 12558401 | Insulinotropic and glucagonotropic effects of beta-lactoglobulin | 🖼🧊📄§ | 2026-02-24 | 2040-11-20 | 0 | 31 |
| 12558577 | Anti-human Trop-2 antibody and application thereof | 🖼🧊📄§ | 2026-02-24 | 2040-10-12 | 0 | 31 |
| 12559563 | Müllerian inhibiting substance type 2 receptor (MISIIR)-specific CAR T cells for the treatment of ovarian cancer and other gynecologic malignancies | 🖼🧊📄§ | 2026-02-24 | 2040-04-14 | 0 | 31 |
| 12558388 | Use of radix actinidiae chinensis and extract thereof in preparation of medicine for treating ulcerative colitis | 🖼🧊📄§ | 2026-02-24 | 2044-01-12 | 0 | 31 |
| 12559569 | Methods of treating bleeding disorders by administration of chimeras comprising anti-von Willebrand factor antibodies and clotting factors | 🖼🧊📄§ | 2026-02-24 | 2042-12-20 | 0 | 31 |
| 12558350 | Compositions and methods for treatment | 🖼🧊📄§ | 2026-02-24 | 2042-07-27 | 0 | 31 |
| 12558372 | Polyhydroxyalkanoates for use in the prevention or treatment of an overweight or obesity condition, or of metabolic dysfunctions related to said condition | 🖼🧊📄§ | 2026-02-24 | 2039-07-24 | 0 | 31 |
| 12559552 | IL-23 and TNF-alpha binding bi-specific heavy chain polypeptides | 🖼🧊📄§ | 2026-02-24 | 2040-06-19 | 0 | 31 |
| 12558339 | Composition comprising (7S)-(+)-cyclopentyl carbarmic acid, 8,8-dimethyl-2-oxo-6,7-dihydro-2H,8H-pyrano[3,2-g]chromen-7-yl-ester as active ingredient for prevention, alleviation, or treatment of eye disease | 🖼🧊📄§ | 2026-02-24 | 2042-01-05 | 0 | 31 |
| 12558387 | Multi-virus anti-infectivity and pro-immunity assembly | 🖼🧊📄§ | 2026-02-24 | 2042-06-07 | 0 | 31 |
| 12559733 | Optimization of type IV BRAF inhibitors for the treatment of melanoma | 🖼🧊📄§ | 2026-02-24 | 2041-08-23 | 0 | 31 |
| 12559549 | Antibody binding to super-repressor IκB (srIκB) or antigen binding fragment thereof | 🖼🧊📄§ | 2026-02-24 | 2040-12-31 | 0 | 31 |
| 12558361 | Method and composition for treating non-cirrhotic NASH | 🖼🧊📄§ | 2026-02-24 | 2044-03-15 | 0 | 31 |
| 12558398 | Inflammatory disease treatment with complement inhibitors | 🖼🧊📄§ | 2026-02-24 | 2040-06-04 | 0 | 31 |